Intranasal Vaccination with a Recombinant Adeno-Associated Virus Type 6 Encoding SapM Confers Protection Against Tuberculosis.

In the spleen, the rAAV6-SapM group showed a trend toward fewer CFUs compared with rAAV6-vector controls, although this difference did not reach statistical significance ( Figure 4 B).

also in 53,322 other papers